Ignite Creation Date:
2024-05-05 @ 10:00 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00001021
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase I Multicenter Study of the Safety and Immunogenicity of MN rgp120HIV-1 Vaccine Given Either Alone or in Combination With IIIB rgp120HIV-1 Vaccine in Healthy Adult Subjects NOTE Original Study Extended ONLY for Patients Previously Enrolled on VEU 009
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID